1. Home
  2. DARE vs TRT Comparison

DARE vs TRT Comparison

Compare DARE & TRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DARE
  • TRT
  • Stock Information
  • Founded
  • DARE 2015
  • TRT 1958
  • Country
  • DARE United States
  • TRT United States
  • Employees
  • DARE N/A
  • TRT N/A
  • Industry
  • DARE Biotechnology: Pharmaceutical Preparations
  • TRT Industrial Machinery/Components
  • Sector
  • DARE Health Care
  • TRT Technology
  • Exchange
  • DARE Nasdaq
  • TRT Nasdaq
  • Market Cap
  • DARE 28.0M
  • TRT 22.7M
  • IPO Year
  • DARE N/A
  • TRT N/A
  • Fundamental
  • Price
  • DARE $2.25
  • TRT $6.22
  • Analyst Decision
  • DARE Strong Buy
  • TRT
  • Analyst Count
  • DARE 2
  • TRT 0
  • Target Price
  • DARE $10.00
  • TRT N/A
  • AVG Volume (30 Days)
  • DARE 123.3K
  • TRT 15.9K
  • Earning Date
  • DARE 11-13-2025
  • TRT 11-11-2025
  • Dividend Yield
  • DARE N/A
  • TRT N/A
  • EPS Growth
  • DARE N/A
  • TRT N/A
  • EPS
  • DARE N/A
  • TRT N/A
  • Revenue
  • DARE N/A
  • TRT $36,473,000.00
  • Revenue This Year
  • DARE $6,864.02
  • TRT N/A
  • Revenue Next Year
  • DARE $4,922.46
  • TRT N/A
  • P/E Ratio
  • DARE N/A
  • TRT N/A
  • Revenue Growth
  • DARE N/A
  • TRT N/A
  • 52 Week Low
  • DARE $1.83
  • TRT $4.62
  • 52 Week High
  • DARE $9.19
  • TRT $7.88
  • Technical
  • Relative Strength Index (RSI)
  • DARE 61.86
  • TRT 64.98
  • Support Level
  • DARE $2.11
  • TRT $5.61
  • Resistance Level
  • DARE $2.28
  • TRT $6.20
  • Average True Range (ATR)
  • DARE 0.07
  • TRT 0.24
  • MACD
  • DARE 0.02
  • TRT 0.07
  • Stochastic Oscillator
  • DARE 91.96
  • TRT 77.24

About DARE Dare Bioscience Inc.

Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.

About TRT Trio-Tech International

Trio-Tech International is a provider of third-party semiconductor testing and burn-in services through its laboratories in Southeast Asia. The company operates in four segments namely Manufacturing, Testing services, Distribution, and Real Estate. Its Manufacturing segment manufactures both front-end and back-end semiconductor test equipment and related peripherals. The Testing Services segment renders services to the manufacturer and purchaser of semiconductors and other entities. Its Distribution segment is involved in the distribution of its products. The company's Real Estate segment consists of investment in real estate. Its geographical area of operations includes the United States, Singapore, Malaysia, Thailand, and China. It derives maximum revenue from Testing services Segment.

Share on Social Networks: